Section Arrow
Quote
BCRX.NASDAQ
- BioCryst Pharmaceuticals
Quotes are at least 15-min delayed:2026/08/12 08:40 EDT
Pre Market
Last
 10.23
-0.11 (-1.06%)
Bid
10.01
Ask
10.57
High 10.6 
Low 10.23 
Volume 7.00K 
Regular Hours (Closed)
Last
 10.34
+0.5 (+5.08%)
Day High 
10.59 
Prev. Close
9.84 
1-M High
10.23 
Volume 
5.03M 
Bid
10.01
Ask
10.57
Day Low
9.78 
Open
9.86 
1-M Low
8.76 
Market Cap 
2.51B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 9.29 
20-SMA 9.34 
50-SMA 9.33 
52-W High 11.22 
52-W Low 6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.40/0.59
Enterprise Value
2.95B
Balance Sheet
Book Value Per Share
-1.78
Cash Flow
Cash Flow Yield
0.16
Income Statement
Total Revenue
874.84M
Operating Revenue Per Share
1.24
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OGIOrganigram Global Inc1.23+0.18+17.14%-- 
Pre Market 1.168 -0.062 -5.04%
HIMSHims & Hers Health30.51-1.26-3.97%-- 
Pre Market 30.68 +0.17 +0.56%
VTRSViatris16.28------ 
Pre Market 16.28 0 0.00%
HLNHaleon plc9.93----20.3PE
Pre Market 9.93 0 0.00%
TEVATeva Pharmaceutical Industries Limited36.48+0.34+0.94%60.23PE
Pre Market 36.7 +0.22 +0.60%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.